Apalutamide Not Yet Recruiting Phase 2 Trials for Stage IV Prostate Adenocarcinoma AJCC v7 / Castration Levels of Testosterone / PSA Progression / Castration-Resistant Prostate Carcinoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03503344Apalutamide With or Without Stereotactic Body Radiation Therapy in Treating Participants With Castration-Resistant Prostate Cancer